期刊文献+

带膜支架对老年冠状动脉介入治疗术中冠状动脉穿孔患者的疗效 被引量:1

Efficiency of covered stent on elderly patients with coronary perforation during percutaneous coronary intervention
下载PDF
导出
摘要 目的评价带膜支架治疗经皮冠状动脉介入治疗(PCI)术中发生冠状动脉穿孔老年患者的疗效。方法从2004年6月至2011年6月,本中心共对8例PCI术中发生冠状动脉穿孔后植入带膜支架的老年患者进行了1年随访,观察其主要心脏不良事件(MACE)发生率。结果8例患者中男4例,女4例,年龄65±76岁,平均(70.4±4.1)岁。植入带膜支架直径平均(3.2±O.3)mm,长度平均(21.0±3.4)mm,所有患者破口均被成功封闭,术中无死亡病例。随访1年,1例急性前壁心肌梗死患者术后19天因肺部感染导致多器官功能衰竭而死亡,其余患者均无心绞痛发作。随访期间死亡率为12.5%(1/8),MACE发生率为12.5%(1/8)。结论带膜支架治疗老年冠状动脉穿孔能达到较好的近期和远期疗效。 Objective To evaluate the efficiency of covered stent implantation on the elderly patients with coronary perforation occurred in percutaneous coronary intervention (PCI). Methods From June 2004 to June 2011, 8 cases having coronary perforation during PCI received covered stents implantation. They were followed up for 1 year for the occurrence of major adverse cardiac events (MACE). Results There were 4 males and 4 females with an age ranging from 65 to 76 years mean (70.4 ± 4.1) years. Average diameter of implanted covered stents was (3.2± 0.3)mm, and average length was (21.0 ±3.4)mm. In all patients, perforation was successfully closed, while no patient died in the procedure. One patient with acute anterior myocardial wall infarction died of multiple organ failure due to lung infection at day 19 after PCI. No patient had angina pectoris during 1 year follow-up. Both of mortality and MACE rate were 12.5% (1/8) in 1 year after PCI. Conclusion Treatment of covered stent in elderly patients with coronary perforation can achieve good efficacy.
出处 《中华老年多器官疾病杂志》 2013年第3期172-175,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 军队临床高新技术重大项目(2010GXJS001)
关键词 冠状动脉穿孔 经皮冠状动脉介入术 带膜支架 老年人 coronary perforation percutaneous coronary intervention covered stent elderly
  • 相关文献

参考文献15

  • 1Johnman C, Oldroyd KG; Mackay DF, et al. Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31758 patients treated between 2000 and 2007[J]. Circ Cardiovasc Interv, 2010, 3(4): 341-345.
  • 2Hendry C, Fraser D, Eichhofer J, et al. Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience[J]. Eurointervention, 2012, 8(1): 79-86.
  • 3Galassi AR, Tomasello SD, Reifart N, et al. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry[J]. Eurolntervention, 2011, 7(4): 472-479.
  • 4Ellis SG~ Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome[J]. Circulation, 1994, 90(6): 2725-2730.
  • 5A1-Lamee R, Ielasi A, Latib A, et al. Incidence, predictors, management, immediate and long-term outcomes following grade II1 coronary perforation[J]. JACC Cardiovasc Interv, 2011, 4(1): 87-95.
  • 6Skolnick AH, Reynolds HIL White HD, et al. Comparison of late results of percutaneous coronary intervention among stable patients ~< 65 versus > 65 years of age with an occluded infarct related artery (from the Occluded Artery Trial) [J]. Am J Cardiol, 2012, 109(5): 614-619.
  • 7Shirakabe A, Takano H, Nakamura S, et al. Coronary perforation during percutaneous coronary intervention[J]. Int Heart J, 2007, 48(1): 1-9.
  • 8Eggebrecht H, Ritzel A, von Birgelen C, et al. Acute and long-term outcome after coronary artery perforation during percutaneous coronary interventions[J]. Z Kardiol, 2004, 93(10): 791-798.
  • 9Fasseas P, Orford JL, Panetta CJ, et al. Incidence, correlates, management, and clinical outcome of coronary perforation : analysis of 16298 procedures[J]. Am Heart J, 2004, 147(1): 140-145.
  • 10Javaid A, Buch AN, Satler LF, et al. Management andoutcomes of coronary artery perforation during percutaneous coronary intervention[J]. Am J Cardiol, 2006, 98(7): 911-914.

同被引文献7

  • 1Shimony A, Joseph L, Mottillo S, et al, Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis[J]. Can J Cardiol, 2011 , 27 (6) : 843 - 850.
  • 2Georgiadou P, Karavolias G, Sbarouni E, et al. Coronary artery perforation in patients undergoing percutaneous coronary intervention: a single-centre report[J]. Acute Card Care, 2009, 11 (4) : 216 -221.
  • 3Kini AS, Rafael 0 C, Sarkar K, et al. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use [J]. Catheter Cardiovasc Interv, 2009, 74 (5) : 700 - 707.
  • 4Ellis S G, Ajluni S, Arnold A Z, et al, Increased coronary perforation in the new device era. Incidence, classification management, and outcomej J]: Circulation, 1994,90(6): 2725 -2730.
  • 5Cevik C, Wilborn T, Corona R, et al, Post-cardiac injury syndrome following transvenous pacemaker insertion: A case report and review of the literature[J]. Heart Lung Cire, 2009,18(6): 379 -383.
  • 6Levy J H, Adkinson N F Jr. Anaphylaxis during cardiac surgery: implications for clinicians [J]. Anesth Analg, 2008, 106 (2): 392 - 403.
  • 7Pershad A, Yarkoni A, Biglari D. Management of distal coronary perforations[J]. J Invasive Cardiol,2008, 20(6): E187 -EI91.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部